Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake

Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake

Background: The management of atrial fibrillation and/or flutter (AF) patients requiring percutaneous coronary intervention (PCI) has evolved significantly. The Canadian Cardiovascular Society AF guidelines, last updated in 2020, seek to aid physicians in balancing both bleeding and thrombotic risks...

Full description

Bibliographic Details
Main Authors:	Marie-Claude Beaulieu, MD, Laurie-Anne Boivin-Proulx, MD, Alexis Matteau, MD, SM, Samer Mansour, MD, Jean-François Gobeil, MD, Brian J. Potter, MDCM, SM
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	CJC Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589790X21000974

Similar Items

Prehospital STEMI Referral Systems and Sex-Related Bias in Canada: A National Survey
by: Laurie-Anne Boivin-Proulx, MD, MSc, et al.
Published: (2022-10-01)

Effect of Real-Time Physician Oversight of Prehospital STEMI Diagnosis on ECG-Inappropriate and False Positive Catheterization Laboratory Activation
by: Laurie-Anne Boivin-Proulx, MD, et al.
Published: (2021-04-01)

Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin Among Obese Patients With Atrial Fibrillation
by: Laurie-Anne Boivin-Proulx, MD, MSc, et al.
Published: (2022-04-01)

The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation
by: Satoshi Ogawa, MD, et al.
Published: (2013-06-01)

Clinical Discussions in Antithrombotic Therapy Management in Patients With Atrial Fibrillation: A Delphi Consensus Panel
by: Nicola Mumoli, MD, et al.
Published: (2020-11-01)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022-02-01)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021-09-01)

Antithrombotic Therapy According to the Guidelines Issued by the Japanese Circulation Society in Patients with Nonvalvular Paroxysmal Atrial Fibrillation without Thromboembolic Risk Factors
by: Mahito Ozawa, MD, et al.
Published: (2009-01-01)

Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Felice Gragnano, et al.
Published: (2023-12-01)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
by: Wenbin Lu, et al.
Published: (2021-10-01)

Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?
by: E. P. Panchenko
Published: (2020-12-01)

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
by: Caylie M. Poirier, PharmD, ACPR, et al.
Published: (2023-11-01)

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention
by: Toka Hamaguchi, MD, et al.
Published: (2021-11-01)

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada
by: Theresa E. Eberhardt, PharmD, ACPR, et al.
Published: (2022-04-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Leonardo De Luca, et al.
Published: (2022-01-01)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention.
by: Jiesuck Park, et al.
Published: (2020-01-01)

Choosing antithrombotics for atrial fibrillation in primary care
by: Mustafa, M, et al.
Published: (2020)

Antithrombotic Management and Outcomes of Anterior ST-Elevation Myocardial Infarction With New-Onset Wall Motion Abnormalities in Men and Women
by: Laurie-Anne Boivin-Proulx, MD, MSc, et al.
Published: (2024-02-01)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
by: Marek Koziński, et al.
Published: (2020-06-01)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01)

APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
by: E. A. Ushkalova, et al.
Published: (2017-05-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

ATRIAL FIBRILLATION AND HEART FAILURE: APPROACHES TO ANTITHROMBOTIC THERAPY
by: B. A. Tatarsky, et al.
Published: (2017-08-01)

Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
by: Oh Young Bang, et al.
Published: (2022-03-01)

Management of Acute Coronary Syndromes Beyond the First Year: A Canadian Clinical Practice Survey
by: Khai-Tuan A. Bui, et al.
Published: (2020-11-01)

Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01)

A network meta-analysis of the antithrombotic strategies in patients with atrial fibrillation and percutaneous coronary interventions: Focus on bleeding
by: Kyriakos Dimitriadis, et al.
Published: (2023-09-01)

COMBINED ANTITHROMBOTIC THERAPY IN CASE OF PLANNED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ATRIAL FIBRILLATION IN ACTUAL CLINICAL PRACTICE
by: N. Yu. Khorkova, et al.
Published: (2018-12-01)

Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2
by: Lena Rivard, MD, MSc, et al.
Published: (2021-09-01)

The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients
by: Eero Anttonen, MD, et al.
Published: (2021-10-01)

Cryoballoon Ablation for Atrial Fibrillation
by: Jason G. Andrade, MD, et al.
Published: (2012-03-01)

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study
by: Cecilia Politi, et al.
Published: (2016-02-01)

ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Analysis of antithrombotic therapy of atrial fibrillation in international and Russian registries
by: O. V. Reshetko, et al.
Published: (2019-08-01)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
by: Wilbert Bor, et al.
Published: (2020-06-01)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
by: Shin‐Yi Lin, et al.
Published: (2022-03-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES
by: N. A. Koziolova, et al.
Published: (2015-08-01)